Back

Single-Cell Transcriptomic Mapping of PD-L1/TLR4 Remodeling Informs Topical Immunoprevention Timing in Skin Carcinogenesis

Wei, R.; Pokhrel, R.; Stratton, D.; Centuori, S.; Curiel-Lewandrowski, C. N.; Wondrak, G. T.; Dickinson, S. E.; LaFleur, B. J.; Sun, X.

2026-06-04 cancer biology
10.64898/2026.06.01.729458 bioRxiv
Show abstract

Cutaneous squamous cell carcinoma (cSCC) represents a growing public health burden, with incidence projected to increase 23-29% over the coming decade. Topical immunoprevention strategies targeting the PD-L1/PD-1 and TLR4 axes have demonstrated preclinical efficacy, yet optimal intervention timing in humans remains undefined. To address this gap, single-cell RNA sequencing was performed on matched sun-protected (SP), sun-damaged (SD), and actinic keratosis (AK) biopsies from the same individuals, along with independent cSCC cases. Immune checkpoint and innate inflammatory signals were detectable as early as SD skin, prior to histologically confirmed dysplasia. Monotonically increasing expression of CD274 (PD-L1), CTLA4, PDCD1, CD27, and STAT1, alongside progressive TLR4-MYD88 innate immune signaling, was revealed through pseudobulk data analysis, with earliest upregulation at the SD stage. Fuzzy c-means trajectory clustering identified cell-typespecific programs across dendritic cells, macrophages, T cells, fibroblasts, endothelial cells, and keratinocytes. Dendritic cells shifted from early inflammatory antigen-presenting programs toward late PD-L1/IFN-regulatory states; macrophages showed monotonically increasing TLR4-associated myeloid activation; and T cells defined a "hot but exhausted" microenvironment in established cSCC. These findings identify SD and AK as biologically active stages for topical immunoprevention and provide a cellular roadmap for PD-L1/PD-1 and TLR4 blockade strategies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
JID Innovations
11 papers in training set
Top 0.1%
18.9%
2
Journal of Investigative Dermatology
49 papers in training set
Top 0.1%
12.9%
3
Nature Communications
5641 papers in training set
Top 18%
9.9%
4
Experimental Dermatology
10 papers in training set
Top 0.1%
9.9%
50% of probability mass above
5
British Journal of Dermatology
11 papers in training set
Top 0.1%
8.0%
6
Journal of Translational Medicine
57 papers in training set
Top 0.1%
5.6%
7
Genome Medicine
183 papers in training set
Top 0.9%
4.1%
8
JCI Insight
277 papers in training set
Top 3%
2.4%
9
eLife
5828 papers in training set
Top 43%
2.2%
10
Scientific Reports
3612 papers in training set
Top 50%
1.9%
11
Cancer Research
130 papers in training set
Top 2%
1.5%
12
PLOS ONE
5266 papers in training set
Top 52%
1.4%
13
Cell Reports Medicine
153 papers in training set
Top 3%
1.4%
14
Science Advances
1243 papers in training set
Top 23%
1.4%
15
Communications Biology
993 papers in training set
Top 20%
1.2%
16
EMBO Reports
263 papers in training set
Top 6%
1.1%
17
The Journal of Pathology
26 papers in training set
Top 0.7%
0.9%
18
British Journal of Cancer
49 papers in training set
Top 1%
0.9%
19
Advanced Science
286 papers in training set
Top 9%
0.9%
20
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 40%
0.9%
21
Communications Medicine
113 papers in training set
Top 4%
0.9%
22
Cell Death & Disease
21 papers in training set
Top 0.5%
0.6%